Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01713127Phase 2Terminated
A Phase 2 trial of remifentanil in pain, sponsored by Seoul National University Hospital. Started Aug 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01713127.